TIVDAQ
DEAD

Serial Number

90675409

Owner

SEAGEN INC.

Attorney

Harold Milstein

Filing Date

Apr 27, 2021

Add to watchlist:

No watchlists yet
View on USPTO

TIVDAQ Trademark

Serial Number: 90675409

TIVDAQ is a trademark filed by SEAGEN INC. on April 27, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

SEAGEN INC. (66 trademarks)

21823 30TH DRIVE S.E.
BOTHELL, WA 98021

Entity Type: 03

Trademark Details

Filing Date

April 27, 2021

Registration Date

Not Registered

Published for Opposition

February 1, 2022

Goods & Services

Pharmaceutical preparations for use in humans, namely, chemotherapeutics for the treatment of diseases and conditions; Pharmaceutical preparations for use in humans, namely, biopharmaceuticals for the treatment of diseases and conditions, namely, cancer; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology

Biotechnology research, namely, research and development of pharmaceutical preparations for use in humans; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of cancer, autoimmune diseases, inflammatory disorders, gastroenterological disorders and for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 29, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 29, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 1, 2023 EXRA
SOU EXTENSION 3 GRANTED
Jul 28, 2023 EX3G
SOU EXTENSION 3 FILED
Jul 28, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 28, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 14, 2023 EXRA
SOU EXTENSION 2 GRANTED
Feb 10, 2023 EX2G
SOU EXTENSION 2 FILED
Feb 10, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 10, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 25, 2022 EXRA
SOU EXTENSION 1 GRANTED
Aug 23, 2022 EX1G
SOU EXTENSION 1 FILED
Aug 23, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 23, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 15, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 15, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 15, 2022 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 29, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 1, 2022 NPUB
PUBLISHED FOR OPPOSITION
Feb 1, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 12, 2022 NONP
ASSIGNED TO LIE
Dec 30, 2021 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 28, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 28, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 28, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 28, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 28, 2021 CNEA
ASSIGNED TO EXAMINER
Dec 22, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 2, 2021 NWOS
NEW APPLICATION ENTERED
Apr 30, 2021 NWAP